COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 3014: Articles 30131-30140  | Next

Social distancing strategies for curbing the COVID-19 epidemic
Kissler, S. M., Tedijanto, C., Lipsitch, M., Grad, Y.
10.1101/2020.03.22.20041079 — Posted: 2020-03-24 Discussion: Onsite
Window of Opportunity for Mitigation to Prevent Overflow of ICU capacity in Chicago by COVID-19
Maslov, S., Goldenfeld, N.
10.1101/2020.03.20.20040048 — Posted: 2020-03-24
Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany
magal, p., Webb, G.
10.1101/2020.03.21.20040154 — Posted: 2020-03-24 Discussion: Offsite
A comparative multi-centre study on the clinical and imaging features of comfirmed and uncomfirmed patients with COVID-19
Miao, C., Zhuang, J., Jin, M., Xiong, H., Huang, P., Zhao, Q., Miao, L., Du, J., Yang, X., Huang, P., Hong, J.
10.1101/2020.03.22.20040782 — Posted: 2020-03-24 Discussion: Offsite
Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients
Chen, X., Hu, W., Ling, J., Mo, P., Zhang, Y., Jiang, Q., Ma, Z., Cao, Q., Deng, L., Song, S., Zheng, R., Gao, S., Ke, H., Gui, X., Lundkvist, A., Li, J., Lindahl, J. F., Xiong, Y.
10.1101/2020.03.22.20040774 — Posted: 2020-03-24 Discussion: Onsite
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China
Shi, P., Dong, Y., Yan, H., Li, X., Zhao, C., Liu, W., He, M., Tang, S., Xi, S.
10.1101/2020.03.22.20038919 — Posted: 2020-03-24 Discussion: Onsite
Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site.
Davidson, A. D., Kavangh Williamson, M., Lewis, S., Shoemark, D., Carroll, M. W., Heesom, K., Zambon, M., Ellis, J., Lewis, P. A., Hiscox, J. A., Matthews, D. A.
10.1101/2020.03.22.002204 — Posted: 2020-03-24 Discussion: Onsite | Offsite
SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems
Blanco-Melo, D., Nilsson-Payant, B., Liu, W.-C., Moeller, R., Panis, M., Sachs, D., Albrecht, R., tenOever, B. R.
10.1101/2020.03.24.004655 — Posted: 2020-03-24 Discussion: Onsite | Offsite
Potential Factors for Prediction of Disease Severity of COVID-19 Patients
zhang, h., wang, x., fu, z., luo, m., zhang, z., zhang, k., he, y., wan, d., zhang, l., wang, j., yan, x., han, m., chen, y.
10.1101/2020.03.20.20039818 — Posted: 2020-03-23
Modelling the Potential Health Impact of the COVID-19 Pandemic on a Hypothetical European Country
Wilson, N., Telfar Barnard, L., Kvalsig, A., Verrall, A., Baker, M. G., Schwehm, M.
10.1101/2020.03.20.20039776 — Posted: 2020-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).